Análise retrospectiva multicêntrica | Oxigenação extracorpórea venovenosa (VV-ECMO) na insuficiência respiratória grave em pacientes oncológicos adultos.
17 Fev, 2022 | 14:18h
Comentário no Twitter
VV #ECMO in adults with cancer developing severe respiratory failure: survival remains poor, no significant advantage, carefully select! Low PLT, elevated lactate, disease status: adverse prognostic factors to be considered as deciding to provide #ECLS.
🖇️ https://t.co/igatEJH3VS pic.twitter.com/vl7UQKauB0— Intensive Care Medicine (@yourICM) February 12, 2022